ENvue Medical, Inc. cotiza a 0.35 USD y tiene una capitalización bursátil de $324225. En los últimos 12 meses ha facturado $2M con un margen de flujo de caja libre del -369.4%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
ENvue Medical, Inc., through its subsidiaries, focuses on non-invasive biological response-activating devices that target biofilm prevention, pain therapy, wound healing, and at home administration without medical professional assistance. Its product portfolio includes UroShield, an ultrasound-based product that is des…
| Periodo | 2019-11 | 2019-08 | 2019-05 | 2019-04 |
|---|---|---|---|---|
| Real | $-3168.00 | $-4224.00 | $-8997.12 | $-4752.00 |
| Estimado | $-5280.00 | $-5280.00 | $-5544.00 | $-3432.00 |
| Sorpresa | +40.0% | +20.0% | -62.3% | -38.5% |
| Métrica | FEED | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 6.0% | 57.0% | -51.0% |
| Operating Margin | -896.5% | -38.6% | -857.9% |
| Net Margin | -712.3% | -33.6% | -678.7% |
| FCF Margin | -369.4% | -13.9% | -355.6% |
| ROE | -54.3% | -40.4% | -13.9% |
| ROA | -44.2% | -32.0% | -12.2% |
| Current Ratio | 1.09 | 2.84 | -1.75 |
| Debt / Equity | — | 0.28 | — |